Biotechnology and bioengineering – Page 16
-
BusinessLilly and CureVac to collaborate on mRNA cancer vaccines
Deal could see CureVac net up to $1.8 billion in upfront and milestone payments
-
ResearchPeptide vehicle drives Crispr delivery of Cas9 into cells
Gene editing enzyme ferried via endocytic pathway
-
ResearchCrispr gene editor can now alter RNA as well as DNA
Gene editing technique is developing apace with two new technologies unveiled
-
OpinionRise of the biologics
Antibodies, RNA and gene therapy don’t necessarily compete with small molecule drugs – and they all rely on chemistry
-
PodcastA Crack in Creation by Jennifer Doudna – Book club
The development of Crispr, and the ethical questions raised by new genome editing techniques
-
BusinessUS to invest $160m in cancer partnership
Funds will be backed up with $55m from 11 companies to advance new cancer treatments that harness the immune system
-
BusinessBASF to buy Bayer seeds and herbicides
€5.9bn sale will help satisfy competition regulators’ worries over Bayer–Monsanto merger
-
ResearchFirst for cells as they're made to manufacture fluorinated bioplastics
Genetically modified bacteria could make synthesis of new materials more sustainable
-
BusinessAmgen partners to launch biosimilars in China
US biopharma and Chinese generics firm will co-develop medicines from Amgen’s pipeline focused on inflammation and oncology
-
BusinessTakeda tightens focus on core areas with multiple deals
Japanese firm is remodelling its R&D efforts through collaboration and licensing deals, and selling off non-core businesses
-
ResearchGut bugs hijacking our signalling could treat disease
Gastrointestinal microflora found to produce a profusion of molecules that can affect human health
-
-
ResearchGolden touch to detect ultra-small quantities of DNA
New method uses gold nanoprobes to overcome the problems of PCR detecting small nucleic acids
-
ResearchSpace travel microbes turn urine into polymers
Researchers are trying to develop yeast that could convert human waste into food for long space flights
-
BusinessUS court denies Amgen appeal over Pfizer biosimilar
Amgen has lost its bid to compel Pfizer to divulge information about its version of anaemia drug Epogen
-
ResearchCrispr first as disease-causing mutation edited in human embryos
Faulty gene that causes serious heart condition corrected
-
-
Research‘New era’ of designer proteins for medicines and materials
Platform computed thousands of stable designs for short proteins, up from two previous designs
-
ResearchLiving bacteria write pictures and movies to DNA
Crispr–Cas9 tool used to store information in the genome of living E. coli
-
ResearchSynthetic ‘enzyme’ matches natural counterparts for catalytic power
Nanoparticle, nucleic acid and peptide trio mimics peroxidase enzymes